We are live on ! Find out more
ASBPW

Aspire Biopharma Warrant
ASBPW

36 hedge funds and large institutions have $4.53M invested in Aspire Biopharma Warrant in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

54% more capital invested

Capital invested by funds: $2.94M → $4.53M (+$1.58M)

0% more funds holding

Funds holding: 36 → 36 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

Holders
36
Holders Change
–
Holders Change %
0%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
1
Closed
5
Calls
$2.11M
Puts
–
Net Calls
+$2.11M
Net Calls Change
+$14K

Top Buyers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
+$32.9K
2
LP
LMR Partners
United Kingdom
+$8.4K
3
MP
Mangrove Partners
Connecticut
+$4.35K
4
AC
Athos Capital
Hong Kong
+$1.68K
5
OAC
OMERS Administration Corp
Ontario, Canada
+$1.68K

Top Sellers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
-$29K
2
BCM
Basso Capital Management
Connecticut
-$6K
3
KKRC
Kohlberg Kravis Roberts & Co
New York
-$3K
4
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$1K
5
CH
CVI Holdings
Delaware
-$27
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
26
CAAS Capital Management
New York
$5.99K – – –
DCM
27
Difesa Capital Management
New York
$5.99K – – –
PMAM
28
Picton Mahoney Asset Management
Ontario, Canada
$5K – – –
ACM
29
Atalaya Capital Management
New York
$4K – – –
SFM
30
Spartan Fund Management
Canada
$4K – – –
FSI
31
Flow State Investments
Illinois
$4K +$3.36K +50,049 New
MTCM
32
Mint Tower Capital Management
Netherlands
$2K – – –
OAC
33
OMERS Administration Corp
Ontario, Canada
$2K +$1.68K +25,000 New
CH
34
CVI Holdings
Delaware
$1.97K -$27 -400 -2%
BI
35
Bulldog Investors
New Jersey
$999 – – –
PI
36
PEAK6 Investments
Illinois
$999 – – –
IRC
37
Investors Research Corp
Georgia
$1 – – –
MF
38
Magnetar Financial
Illinois
– -$29K -199,000 Closed
BCM
39
Basso Capital Management
Connecticut
– -$6K -50,400 Closed
KKRC
40
Kohlberg Kravis Roberts & Co
New York
– -$3K -25,273 Closed
COPPSERS
41
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$1K -12,500 Closed
1
2

ASBPW Hedge Fund Activity: Q4 2022 in Review

36 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Aspire Biopharma Warrant (ASBPW) for Q4 2022, worth a combined $4.53M — up 54% from $2.94M a quarter earlier.

Fund positioning in ASBPW was balanced in Q4 2022: 5 funds opened new positions, 5 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Periscope Capital, adding an estimated $32.9K. The largest seller was Magnetar Financial, exiting entirely with an estimated $29K sold.

  • 36 institutional investors held Aspire Biopharma Warrant (ASBPW) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $4.53M of Aspire Biopharma Warrant stock for Q4 2022, up 54% quarter-over-quarter.
  • 5 funds opened new Aspire Biopharma Warrant positions in Q4 2022 and 5 closed out, a net change of 0 holders.
  • The largest Aspire Biopharma Warrant buyer in Q4 2022 was Periscope Capital, an estimated $32.9K added.
  • The largest Aspire Biopharma Warrant seller in Q4 2022 was Magnetar Financial, an estimated $29K sold.

Based on aggregated 13F filings for Q4 2022.